Form 4 Tracker
Daniel J. Lippis

CVP, TAVR · 14 filings · Latest: Oct 8, 2026

Edwards Lifesciences Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
EW
Daniel J. LippisCVP, TAVROct 8, 2026
Sale
$85.65619$53.0K40,033.91
EW
Daniel J. LippisCVP, TAVROct 8, 2026
Option Exercise
$72.68619$45.0K40,652.91
EW
Daniel J. LippisCVP, TAVRSep 11, 2026
Sale
$87.51619$54.2K40,033.91
EW
Daniel J. LippisCVP, TAVRSep 11, 2026
Option Exercise
$72.68619$45.0K40,652.91
EW
Daniel J. LippisCVP, TAVRAug 11, 2026
Sale
$92.03619$57.0K40,033.91
EW
Daniel J. LippisCVP, TAVRAug 11, 2026
Option Exercise
$72.68619$45.0K40,652.91
EW
Lippis Daniel J.—Aug 11, 2026
Proposed Sale
$92.031,857$170.9K—
EW
Daniel J. LippisCVP, TAVRJul 10, 2026
Sale
$91.70619$56.8K40,033.91
EW
Daniel J. LippisCVP, TAVRJul 10, 2026
Option Exercise
$72.68619$45.0K40,652.91
EW
Daniel J. LippisCVP, TAVRJun 30, 2026
Sale
$91.40619$56.6K40,410.91
EW
Daniel J. LippisCVP, TAVRJun 30, 2026
Option Exercise
$72.68619$45.0K41,029.91
EW
Daniel J. LippisCVP, TAVRMay 18, 2026
Sale
$81.14620$50.3K40,410.91
EW
Daniel J. LippisCVP, TAVRMay 18, 2026
Option Exercise
$72.68620$45.1K41,030.91
EW
Lippis Daniel J.—May 18, 2026
Proposed Sale
$81.141,858$150.8K—
EW
Daniel J. LippisCVP, TAVRMay 4, 2026
Sale
$83.981,019$85.6K33,681.91
EW
Daniel J. LippisCVP, TAVRMay 4, 2026
Option Exercise
$59.261,019$60.4K34,700.91
EW
Daniel J. LippisCVP, TAVRMay 1, 2026
Sale
$83.011,019$84.6K33,933.91
EW
Daniel J. LippisCVP, TAVRMay 1, 2026
Option Exercise
$59.261,019$60.4K34,952.91
EW
Lippis Daniel J.—May 4, 2026
Proposed Sale
$83.981,019$85.6K—
EW
Daniel J. LippisCVP, TAVRApr 6, 2026
Sale
$80.981,019$82.5K33,933.91

Page 1 of 2

Next →